欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号BE/V/0016/001
药品名称Tilmovet 250 mg/ml
活性成分
    • TILMICOSIN 250.0 mg/ml
剂型Concentrate for oral solution
上市许可持有人Huvepharma N.V. Uitbreidingsstraat 80 2600 Antwerpen Belgium
参考成员国 - 产品名称Belgium (BE)
Tilmovet 250 mg/ml
互认成员国 - 产品名称
    • Denmark (DK)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
      Tilmovet 250 mg/ml Concentrate for Oral Solution
    • Austria (AT)
    • France (FR)
      TILMOVET 250 MG/ML SOLUTION BUVABLE
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
      Tilmovet 250 mg/ml concentrate for oral solution for pigs, chickens, turkeys and cattle (calves)
    • Hungary (HU)
    • Bulgaria (BG)
    • Czechia (CZ)
    • Romania (RO)
许可日期2008/05/23
最近更新日期2024/12/13
药物ATC编码
    • QJ01FA91 tilmicosin
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase